Clinical Study Results

• BI 224436 - Healthy

  Clinical Study Number	1277.1
  Study Indication	Healthy
  Product	BI 224436
  Generic Name	BI 224436
  Lab Code
  Clinical Phase	I
  Study Title	Safety and pharmacokinetics of single rising oral doses of BI 224436 ZW at 6.2 mg, 12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 400 mg, 600 mg, 900 mg and1200 mg dose levels in healthy male volunteers (randomized, double-blind,placebo-controlled within dose groups).
  Study Document	Trial synopsis 1277.1_CO english